PubMed:21388952
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 450-459 | Glycan_Motif | denotes | T antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00031MO |
| T2 | 557-566 | Glycan_Motif | denotes | T antigen | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00031MO |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-164 | Sentence | denotes | Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. |
| T2 | 165-300 | Sentence | denotes | Activation of oncogenes or inactivation of tumor suppressors in urothelium is considered critical for development of urothelial cancer. |
| T3 | 301-489 | Sentence | denotes | Here we report cloning of the urothelium-specific promoter uroplakin-II (UPK II) and generation of transgenic mice in which expression of SV40 large T antigen is driven by UPK II promoter. |
| T4 | 490-647 | Sentence | denotes | Inactivation of tumor suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling human high-grade carcinoma in situ. |
| T5 | 648-793 | Sentence | denotes | Specific deletion of p53 in urothelial cells using the newly generated UPK II-Cre mice results in normal bladders without any evidence of cancer. |
| T6 | 794-1017 | Sentence | denotes | The high-grade carcinoma in situ in the UPK II-SV40 mice is associated with significant activation of angiogenic signals consisting of hypoxia-inducible factor-1α (HIF-1α) and VEGF and a down-regulation of thrombospondin-1. |
| T7 | 1018-1117 | Sentence | denotes | Interestingly, such pro-angiogenic activity was not associated with progression to invasive cancer. |
| T8 | 1118-1305 | Sentence | denotes | Analysis of bladder-associated microRNAs in carcinoma in situ lesions reveals a pro-angiogenic profile, with specific overexpression of miR-18a and miR-19a and down-regulation of miR-107. |
| T9 | 1306-1436 | Sentence | denotes | A group of microRNAs (miRs) identified as associated with invasive human urothelial cancer remained unchanged in this mouse model. |
| T10 | 1437-1584 | Sentence | denotes | Collectively, our results support the notion that activation of angiogenesis and loss of p53 are not sufficient for progression to invasive cancer. |
| T11 | 1585-1747 | Sentence | denotes | Our studies identify a new mouse model for bladder cancer that can be used to study factors that determine progression to an invasive phenotype of bladder cancer. |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 450-459 | https://glytoucan.org/Structures/Glycans/G00031MO | denotes | T antigen |
| T2 | 557-566 | https://glytoucan.org/Structures/Glycans/G00031MO | denotes | T antigen |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T1 | 450-459 | GlycoEpitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
| T2 | 557-566 | GlycoEpitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 105-112 | http://purl.obolibrary.org/obo/MAT_0000122 | denotes | bladder |
| T2 | 753-761 | http://purl.obolibrary.org/obo/MAT_0000122 | denotes | bladders |
| T3 | 1130-1137 | http://purl.obolibrary.org/obo/MAT_0000122 | denotes | bladder |
| T4 | 1628-1635 | http://purl.obolibrary.org/obo/MAT_0000122 | denotes | bladder |
| T5 | 1732-1739 | http://purl.obolibrary.org/obo/MAT_0000122 | denotes | bladder |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 8-11 | gene:7157 | denotes | p53 |
| T1 | 145-163 | disease:C1334274 | denotes | invasive carcinoma |
| T2 | 8-11 | gene:7157 | denotes | p53 |
| T3 | 105-133 | disease:C0279680 | denotes | bladder urothelial carcinoma |
| T4 | 506-526 | gene:7157 | denotes | tumor suppressor p53 |
| T5 | 629-646 | disease:C0007099 | denotes | carcinoma in situ |
| T6 | 506-526 | gene:7157 | denotes | tumor suppressor p53 |
| T7 | 579-599 | disease:C0007138 | denotes | urothelial carcinoma |
| T8 | 506-526 | gene:7157 | denotes | tumor suppressor p53 |
| T9 | 579-599 | disease:C2145472 | denotes | urothelial carcinoma |
| T10 | 669-672 | gene:7157 | denotes | p53 |
| T11 | 786-792 | disease:C0006826 | denotes | cancer |
| T12 | 669-672 | gene:7157 | denotes | p53 |
| T13 | 786-792 | disease:C1306459 | denotes | cancer |
| T14 | 1000-1016 | gene:7057 | denotes | thrombospondin-1 |
| T15 | 809-826 | disease:C0007099 | denotes | carcinoma in situ |
| T16 | 970-974 | gene:7422 | denotes | VEGF |
| T17 | 809-826 | disease:C0007099 | denotes | carcinoma in situ |
| T18 | 929-956 | gene:3091 | denotes | hypoxia-inducible factor-1α |
| T19 | 809-826 | disease:C0007099 | denotes | carcinoma in situ |
| T20 | 1266-1273 | gene:406979 | denotes | miR-19a |
| T21 | 1162-1179 | disease:C0007099 | denotes | carcinoma in situ |
| T22 | 1526-1529 | gene:7157 | denotes | p53 |
| T23 | 1568-1583 | disease:C0677898 | denotes | invasive cancer |
| R1 | T0 | T1 | associated_with | p53,invasive carcinoma |
| R2 | T2 | T3 | associated_with | p53,bladder urothelial carcinoma |
| R3 | T4 | T5 | associated_with | tumor suppressor p53,carcinoma in situ |
| R4 | T6 | T7 | associated_with | tumor suppressor p53,urothelial carcinoma |
| R5 | T8 | T9 | associated_with | tumor suppressor p53,urothelial carcinoma |
| R6 | T10 | T11 | associated_with | p53,cancer |
| R7 | T12 | T13 | associated_with | p53,cancer |
| R8 | T14 | T15 | associated_with | thrombospondin-1,carcinoma in situ |
| R9 | T16 | T17 | associated_with | VEGF,carcinoma in situ |
| R10 | T18 | T19 | associated_with | hypoxia-inducible factor-1α,carcinoma in situ |
| R11 | T20 | T21 | associated_with | miR-19a,carcinoma in situ |
| R12 | T22 | T23 | associated_with | p53,invasive cancer |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 208-213 | HP_0002664 | denotes | tumor |
| T2 | 293-299 | HP_0002664 | denotes | cancer |
| T3 | 506-511 | HP_0002664 | denotes | tumor |
| T4 | 786-792 | HP_0002664 | denotes | cancer |
| T5 | 1110-1116 | HP_0002664 | denotes | cancer |
| T6 | 1390-1396 | HP_0002664 | denotes | cancer |
| T7 | 1577-1583 | HP_0002664 | denotes | cancer |
| T8 | 1628-1642 | HP_0009725 | denotes | bladder cancer |
| T9 | 1636-1642 | HP_0002664 | denotes | cancer |
| T10 | 1732-1746 | HP_0009725 | denotes | bladder cancer |
| T11 | 1740-1746 | HP_0002664 | denotes | cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_21388952_2_0 | 331-372 | expanded | denotes | urothelium-specific promoter uroplakin-II |
| SS2_21388952_2_0 | 374-380 | abbr | denotes | UPK II |
| SS1_21388952_5_0 | 929-956 | expanded | denotes | hypoxia-inducible factor-1α |
| SS2_21388952_5_0 | 958-964 | abbr | denotes | HIF-1α |
| SS1_21388952_8_0 | 1317-1326 | expanded | denotes | microRNAs |
| SS2_21388952_8_0 | 1328-1332 | abbr | denotes | miRs |
| AE1_21388952_2_0 | SS1_21388952_2_0 | SS2_21388952_2_0 | abbreviatedTo | urothelium-specific promoter uroplakin-II,UPK II |
| AE1_21388952_5_0 | SS1_21388952_5_0 | SS2_21388952_5_0 | abbreviatedTo | hypoxia-inducible factor-1α,HIF-1α |
| AE1_21388952_8_0 | SS1_21388952_8_0 | SS2_21388952_8_0 | abbreviatedTo | microRNAs,miRs |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 21388952-0#8#11#gene7157 | 8-11 | gene7157 | denotes | p53 |
| 21388952-0#105#133#diseaseC0279680 | 105-133 | diseaseC0279680 | denotes | bladder urothelial carcinoma |
| 21388952-0#145#163#diseaseC1334274 | 145-163 | diseaseC1334274 | denotes | invasive carcinoma |
| 21388952-3#16#36#gene7157 | 506-526 | gene7157 | denotes | tumor suppressor p53 |
| 21388952-3#89#109#diseaseC0007138 | 579-599 | diseaseC0007138 | denotes | urothelial carcinoma |
| 21388952-3#89#109#diseaseC2145472 | 579-599 | diseaseC2145472 | denotes | urothelial carcinoma |
| 21388952-9#89#92#gene7157 | 1526-1529 | gene7157 | denotes | p53 |
| 21388952-9#131#146#diseaseC0677898 | 1568-1583 | diseaseC0677898 | denotes | invasive cancer |
| 8#11#gene7157105#133#diseaseC0279680 | 21388952-0#8#11#gene7157 | 21388952-0#105#133#diseaseC0279680 | associated_with | p53,bladder urothelial carcinoma |
| 8#11#gene7157145#163#diseaseC1334274 | 21388952-0#8#11#gene7157 | 21388952-0#145#163#diseaseC1334274 | associated_with | p53,invasive carcinoma |
| 16#36#gene715789#109#diseaseC0007138 | 21388952-3#16#36#gene7157 | 21388952-3#89#109#diseaseC0007138 | associated_with | tumor suppressor p53,urothelial carcinoma |
| 16#36#gene715789#109#diseaseC2145472 | 21388952-3#16#36#gene7157 | 21388952-3#89#109#diseaseC2145472 | associated_with | tumor suppressor p53,urothelial carcinoma |
| 89#92#gene7157131#146#diseaseC0677898 | 21388952-9#89#92#gene7157 | 21388952-9#131#146#diseaseC0677898 | associated_with | p53,invasive cancer |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 450-459 | Glycan | denotes | T antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO |
| T2 | 557-566 | Glycan | denotes | T antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 105-133 | Disease | denotes | bladder urothelial carcinoma | http://purl.obolibrary.org/obo/MONDO_0005611 |
| T2 | 145-163 | Disease | denotes | invasive carcinoma | http://purl.obolibrary.org/obo/MONDO_0040677 |
| T3 | 208-213 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T4 | 293-299 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T5 | 506-511 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T6 | 579-599 | Disease | denotes | urothelial carcinoma | http://purl.obolibrary.org/obo/MONDO_0040679 |
| T7 | 629-646 | Disease | denotes | carcinoma in situ | http://purl.obolibrary.org/obo/MONDO_0004647 |
| T8 | 786-792 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T9 | 809-826 | Disease | denotes | carcinoma in situ | http://purl.obolibrary.org/obo/MONDO_0004647 |
| T10 | 1110-1116 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T11 | 1162-1179 | Disease | denotes | carcinoma in situ | http://purl.obolibrary.org/obo/MONDO_0004647 |
| T12 | 1390-1396 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T13 | 1577-1583 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T14 | 1628-1642 | Disease | denotes | bladder cancer | http://purl.obolibrary.org/obo/MONDO_0001187|http://purl.obolibrary.org/obo/MONDO_0004986|http://purl.obolibrary.org/obo/MONDO_0022578 |
| T17 | 1732-1746 | Disease | denotes | bladder cancer | http://purl.obolibrary.org/obo/MONDO_0001187|http://purl.obolibrary.org/obo/MONDO_0004986|http://purl.obolibrary.org/obo/MONDO_0022578 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 105-112 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T2 | 753-761 | Body_part | denotes | bladders | http://purl.obolibrary.org/obo/MAT_0000122 |
| T3 | 1130-1137 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T4 | 1628-1635 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T5 | 1732-1739 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 450-459 | Glycan | denotes | T antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO |
| T2 | 557-566 | Glycan | denotes | T antigen | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00031MO |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 450-459 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
| T2 | 557-566 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 124-133 | Phenotype | denotes | carcinoma | HP:0030731 |
| T2 | 154-163 | Phenotype | denotes | carcinoma | HP:0030731 |
| T3 | 208-213 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 293-299 | Phenotype | denotes | cancer | HP:0002664 |
| T5 | 506-511 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 590-599 | Phenotype | denotes | carcinoma | HP:0030731 |
| T7 | 629-638 | Phenotype | denotes | carcinoma | HP:0030731 |
| T8 | 786-792 | Phenotype | denotes | cancer | HP:0002664 |
| T9 | 809-818 | Phenotype | denotes | carcinoma | HP:0030731 |
| T10 | 929-936 | Phenotype | denotes | hypoxia | HP:0012418 |
| T11 | 1110-1116 | Phenotype | denotes | cancer | HP:0002664 |
| T12 | 1162-1171 | Phenotype | denotes | carcinoma | HP:0030731 |
| T13 | 1390-1396 | Phenotype | denotes | cancer | HP:0002664 |
| T14 | 1577-1583 | Phenotype | denotes | cancer | HP:0002664 |
| T15 | 1628-1642 | Phenotype | denotes | bladder cancer | HP:0009725 |
| T16 | 1732-1746 | Phenotype | denotes | bladder cancer | HP:0009725 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 676-692 | Cell | denotes | urothelial cells | http://purl.obolibrary.org/obo/CL:0000731 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 105-133 | Disease | denotes | bladder urothelial carcinoma | MONDO:0005611 |
| T2 | 145-163 | Disease | denotes | invasive carcinoma | MONDO:0040677 |
| T3 | 208-213 | Disease | denotes | tumor | MONDO:0005070 |
| T4 | 293-299 | Disease | denotes | cancer | MONDO:0004992 |
| T5 | 506-511 | Disease | denotes | tumor | MONDO:0005070 |
| T6 | 579-599 | Disease | denotes | urothelial carcinoma | MONDO:0040679 |
| T7 | 629-646 | Disease | denotes | carcinoma in situ | MONDO:0004647 |
| T8 | 786-792 | Disease | denotes | cancer | MONDO:0004992 |
| T9 | 809-826 | Disease | denotes | carcinoma in situ | MONDO:0004647 |
| T10 | 1110-1116 | Disease | denotes | cancer | MONDO:0004992 |
| T11 | 1162-1179 | Disease | denotes | carcinoma in situ | MONDO:0004647 |
| T12 | 1390-1396 | Disease | denotes | cancer | MONDO:0004992 |
| T13 | 1577-1583 | Disease | denotes | cancer | MONDO:0004992 |
| T14 | 1628-1642 | Disease | denotes | bladder cancer | MONDO:0004986|MONDO:0022578 |
| T16 | 1732-1746 | Disease | denotes | bladder cancer | MONDO:0004986|MONDO:0022578 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 105-112 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T3 | 229-239 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T5 | 331-341 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T7 | 538-548 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T9 | 676-692 | Body_part | denotes | urothelial cells | http://purl.obolibrary.org/obo/CL_0000731 |
| T10 | 1130-1137 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T12 | 1628-1635 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T14 | 1732-1739 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
GlyCosmos15-Taxon
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 411-415 | Organism | denotes | mice | 10088 |
| T2 | 612-617 | Organism | denotes | human | 9606 |
| T3 | 730-734 | Organism | denotes | mice | 10088 |
| T4 | 846-850 | Organism | denotes | mice | 10088 |
| T5 | 1373-1378 | Organism | denotes | human | 9606 |
| T6 | 1424-1429 | Organism | denotes | mouse | 10088|10090 |
| T8 | 1612-1617 | Organism | denotes | mouse | 10088|10090 |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-164 | Sentence | denotes | Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. |
| T2 | 165-300 | Sentence | denotes | Activation of oncogenes or inactivation of tumor suppressors in urothelium is considered critical for development of urothelial cancer. |
| T3 | 301-489 | Sentence | denotes | Here we report cloning of the urothelium-specific promoter uroplakin-II (UPK II) and generation of transgenic mice in which expression of SV40 large T antigen is driven by UPK II promoter. |
| T4 | 490-647 | Sentence | denotes | Inactivation of tumor suppressor p53 and pRb in urothelium by SV40 T antigen resulted in urothelial carcinoma, resembling human high-grade carcinoma in situ. |
| T5 | 648-793 | Sentence | denotes | Specific deletion of p53 in urothelial cells using the newly generated UPK II-Cre mice results in normal bladders without any evidence of cancer. |
| T6 | 794-1017 | Sentence | denotes | The high-grade carcinoma in situ in the UPK II-SV40 mice is associated with significant activation of angiogenic signals consisting of hypoxia-inducible factor-1α (HIF-1α) and VEGF and a down-regulation of thrombospondin-1. |
| T7 | 1018-1117 | Sentence | denotes | Interestingly, such pro-angiogenic activity was not associated with progression to invasive cancer. |
| T8 | 1118-1305 | Sentence | denotes | Analysis of bladder-associated microRNAs in carcinoma in situ lesions reveals a pro-angiogenic profile, with specific overexpression of miR-18a and miR-19a and down-regulation of miR-107. |
| T9 | 1306-1436 | Sentence | denotes | A group of microRNAs (miRs) identified as associated with invasive human urothelial cancer remained unchanged in this mouse model. |
| T10 | 1437-1584 | Sentence | denotes | Collectively, our results support the notion that activation of angiogenesis and loss of p53 are not sufficient for progression to invasive cancer. |
| T11 | 1585-1747 | Sentence | denotes | Our studies identify a new mouse model for bladder cancer that can be used to study factors that determine progression to an invasive phenotype of bladder cancer. |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 450-459 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
| T2 | 557-566 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | T antigen | http://www.glycoepitope.jp/epitopes/EP0020 |
GlyCosmos15-FMA
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 105-112 | Body_part | denotes | bladder | FMA:15900 |
| T2 | 229-239 | Body_part | denotes | urothelium | FMA:67695 |
| T3 | 331-341 | Body_part | denotes | urothelium | FMA:67695 |
| T4 | 538-548 | Body_part | denotes | urothelium | FMA:67695 |
| T5 | 676-692 | Body_part | denotes | urothelial cells | FMA:84127 |
| T6 | 753-761 | Body_part | denotes | bladders | FMA:15900 |
| T7 | 1130-1137 | Body_part | denotes | bladder | FMA:15900 |
| T8 | 1628-1635 | Body_part | denotes | bladder | FMA:15900 |
| T9 | 1732-1739 | Body_part | denotes | bladder | FMA:15900 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 105-112 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T2 | 753-761 | Body_part | denotes | bladders | http://purl.obolibrary.org/obo/MAT_0000122 |
| T3 | 1130-1137 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T4 | 1628-1635 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
| T5 | 1732-1739 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/MAT_0000122 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 411-415 | OrganismTaxon | denotes | mice | 10088 |
| T2 | 612-617 | OrganismTaxon | denotes | human | 9606 |
| T3 | 730-734 | OrganismTaxon | denotes | mice | 10088 |
| T4 | 846-850 | OrganismTaxon | denotes | mice | 10088 |
| T5 | 1373-1378 | OrganismTaxon | denotes | human | 9606 |
| T6 | 1424-1429 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T8 | 1612-1617 | OrganismTaxon | denotes | mouse | 10088|10090 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 105-112 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T3 | 229-239 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T5 | 331-341 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T7 | 538-548 | Body_part | denotes | urothelium | http://purl.obolibrary.org/obo/UBERON_0000365|http://purl.obolibrary.org/obo/UBERON_0004645 |
| T9 | 676-692 | Body_part | denotes | urothelial cells | http://purl.obolibrary.org/obo/CL_0000731 |
| T10 | 1130-1137 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T12 | 1628-1635 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
| T14 | 1732-1739 | Body_part | denotes | bladder | http://purl.obolibrary.org/obo/UBERON_0001255|http://purl.obolibrary.org/obo/UBERON_0018707 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 124-133 | Phenotype | denotes | carcinoma | HP:0030731 |
| T2 | 154-163 | Phenotype | denotes | carcinoma | HP:0030731 |
| T3 | 208-213 | Phenotype | denotes | tumor | HP:0002664 |
| T4 | 293-299 | Phenotype | denotes | cancer | HP:0002664 |
| T5 | 506-511 | Phenotype | denotes | tumor | HP:0002664 |
| T6 | 590-599 | Phenotype | denotes | carcinoma | HP:0030731 |
| T7 | 629-638 | Phenotype | denotes | carcinoma | HP:0030731 |
| T8 | 786-792 | Phenotype | denotes | cancer | HP:0002664 |
| T9 | 809-818 | Phenotype | denotes | carcinoma | HP:0030731 |
| T10 | 929-936 | Phenotype | denotes | hypoxia | HP:0012418 |
| T11 | 1110-1116 | Phenotype | denotes | cancer | HP:0002664 |
| T12 | 1162-1171 | Phenotype | denotes | carcinoma | HP:0030731 |
| T13 | 1390-1396 | Phenotype | denotes | cancer | HP:0002664 |
| T14 | 1577-1583 | Phenotype | denotes | cancer | HP:0002664 |
| T15 | 1628-1642 | Phenotype | denotes | bladder cancer | HP:0009725 |
| T16 | 1732-1746 | Phenotype | denotes | bladder cancer | HP:0009725 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 676-692 | Cell | denotes | urothelial cells | http://purl.obolibrary.org/obo/CL:0000731 |